Association for Research in Vision and Ophthalmology

Neeraj Agarwal, PhD, FARVO, shared his unique perspective of marrying his prior clinical research to his current institutional landscape at the NIH.

Gene therapy with the CRISPR/Cas9 system corrects mutations identified with patient-specific models that use stem cells generated from skin.

Non-destructive imaging and functional assessment of retinal structures formed from human stem cells confirms their similarity to the adult retina.

Study results show that transplanted human retinal stem cells rescue photoreceptors in rabbit retinas for 8 months.

Diabetic retinapathy is one of the leading causes of blindness

Andrew Hartwick, PhD, The College of Optometry at The Ohio State University wants to understand why regardless of normal, standard vision tests, there is still clearly something wrong with pateints' sight.

Study results show that the majority of patients with retinal neovascularization due to proliferative diabetic retinopathy treated with bevacizumab experience total, long-term regression of their symptoms.

Aflibercept exerts anti-angiogenic effects against galectin-1, a galactoside-binding lectin protein and novel angiogenic factor associated with proliferative diabetic retinopathy.

After 12 or 24 monthly injections, ranibizumab, one of three currently available vascular endothelial growth factor antibodies, caused regression of diabetic retinopathy (DR) in at least 75% of patients who had diabetic macular edema and whose DR severity put them at the highest risk of progression to proliferative DR.

Andrew Hartwick, PhD, Associate Professor at The College of Optometry at The Ohio State University discussed his research surrounding traumatic brain injury (TBI) patients who experience increased light sensitivity, or photophobia.

It may seem like elite athletes have a leg up on non-sports players when it comes to eye control, but research out of the University of Bradford in the United Kingdom says that’s not exactly the case.

Patients with the hereditary degenerative eye disease retinitis pigmentosa (RP) may delay their loss of daytime vision by taking a traditional Chinese plant remedy Lycium barbarum also known as goji berry or wolfberry.

A team of surgeons has demonstrated a surgical model using cadavers for total human eye allotransplantation.

"We hope there are strategies for regeneration of the optic nerve and making synaptic connections to the higher order brain structure, because those are the key issues."